alinidine has been researched along with Cardiovascular Stroke in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (50.00) | 18.7374 |
1990's | 3 (30.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Christensen, LP; Lei, L; Tomanek, RJ; Weiss, RM; Zheng, W; Zhou, R | 1 |
Christensen, LP; Dedkov, EI; Tomanek, RJ; Weiss, RM | 1 |
Hugenholtz, PG; Simoons, ML | 1 |
Ballet, A; Ector, H; Heidbüchel, H; Tack, J; Van de Werf, F; Vanneste, L | 1 |
Brzostek, T; Collen, D; Heidbüchel, H; Janssens, L; Lesaffre, E; Mortelmans, L; Scheys, I; Van de Werf, F; Wackers, FJ; Willems, GM | 1 |
Aidonidis, I; Brachmann, J; Kübler, W; Rizos, I; Stavridis, I; Toutouzas, P; Zacharoulis, A | 1 |
Harron, DW; Shanks, RG | 1 |
Simoons, ML | 1 |
Kobinger, W; Lillie, C; Reichhalter, R | 1 |
Andersen, KS; Grong, K; Lekven, J; Stangeland, L; Vik-Mo, H | 1 |
1 review(s) available for alinidine and Cardiovascular Stroke
Article | Year |
---|---|
Pharmacology, clinical pharmacology and potential therapeutic uses of the specific bradycardiac agent alinidine.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Clonidine; Coronary Disease; Drug Evaluation; Heart Rate; Hemodynamics; Humans; Kinetics; Myocardial Infarction; Neurocirculatory Asthenia; Neuroleptanalgesia; Tachycardia | 1985 |
2 trial(s) available for alinidine and Cardiovascular Stroke
Article | Year |
---|---|
Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with alteplase and effect of early administration of a beta-blocker or a bradycardiac agent on their incidence.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Clonidine; Double-Blind Method; Electrocardiography, Ambulatory; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Prognosis; Prospective Studies; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator | 1994 |
Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy.
Topics: Adult; Aged; Arrhythmias, Cardiac; Atenolol; Cardiovascular Agents; Clonidine; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Exercise Test; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Vascular Patency; Ventricular Function, Left | 1993 |
7 other study(ies) available for alinidine and Cardiovascular Stroke
Article | Year |
---|---|
Bradycardia induces angiogenesis, increases coronary reserve, and preserves function of the postinfarcted heart.
Topics: Angiopoietin-1; Angiopoietin-2; Animals; Bradycardia; Cardiovascular Agents; Clonidine; Coronary Vessels; Drug Evaluation, Preclinical; Extracellular Matrix Proteins; Fibroblast Growth Factor 2; Heart Ventricles; Hypertrophy, Left Ventricular; Ligation; Male; Models, Animal; Myocardial Infarction; Myocytes, Cardiac; Neovascularization, Physiologic; Rats; Rats, Sprague-Dawley; Stroke Volume; Ultrasonography; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2004 |
Reduction of heart rate by chronic beta1-adrenoceptor blockade promotes growth of arterioles and preserves coronary perfusion reserve in postinfarcted heart.
Topics: Adrenergic beta-Antagonists; Animals; Arterioles; Atenolol; Cardiac Output; Clonidine; Coronary Vessels; Diastole; Heart Rate; Male; Myocardial Infarction; Myocardial Reperfusion; Neovascularization, Physiologic; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Stroke Volume | 2005 |
Haemodynamic effects of alinidine, a specific sinus node inhibition, in patients with unstable angina or myocardial infarction.
Topics: Adult; Aged; Angina Pectoris; Angina, Unstable; Cardiac Output; Cardiovascular Agents; Clonidine; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction | 1984 |
Electropharmacology of the bradycardic agents alinidine and zatebradine (UL-FS 49) in a conscious canine ventricular arrhythmia model of permanent coronary artery occlusion.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Blood Pressure; Cardiotonic Agents; Clonidine; Coronary Vessels; Dogs; Electric Stimulation; Electrocardiography; Electrophysiology; Evoked Potentials; Female; Male; Myocardial Infarction; Refractory Period, Electrophysiological; Tachycardia, Ventricular | 1995 |
Effect of ST-567 (a specific bradycardiac agent) in patients with unstable angina and myocardial infarction.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Anti-Arrhythmia Agents; Clonidine; Heart Rate; Hemodynamics; Humans; Myocardial Infarction | 1987 |
Effects of alinidine on survival and infarct size in rats with coronary artery occlusion.
Topics: Animals; Blood Pressure; Clonidine; Heart Rate; Male; Myocardial Infarction; Rats | 1988 |
Is reduced cardiac performance the only mechanism for myocardial infarct size reduction during beta adrenergic blockade?
Topics: Animals; Autoradiography; Cardiac Output; Cats; Clonidine; Disease Models, Animal; Heart Rate; Myocardial Infarction; Myocardium; Random Allocation; Timolol | 1986 |